WIC
AVDL

Water Island Capital’s Avadel Pharmaceuticals AVDL Stock Holding History

Water Island Capital’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,087,117
Closed -$23.4M – 101
2025
Q4 		$23.4M Buy
+1,087,117
New +$21.1M 2.53% 12

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Water Island Capital's AVDL Position: Q1 2026 in Review

Water Island Capital sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 1,087,117 shares — an estimated $23.4M sold.

Water Island Capital first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $23.4M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Water Island Capital reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Water Island Capital sold 1,087,117 Avadel Pharmaceuticals shares in Q1 2026, an estimated $23.4M.
  • Water Island Capital first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Water Island Capital's Avadel Pharmaceuticals position peaked at $23.4M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Water Island Capital's 13F filing for Q1 2026, filed 15 May 2026.